Nausea and Vomiting, Chemotherapy-Induced Clinical Trial
Official title:
A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects
Casopitant may affect liver enzymes that metabolize ketoconazole. This study is designed to test the safety and the extent of the Casopitant affect on ketoconazole levels in healthy human subjects.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00404378 -
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
|
Phase 1 | |
Completed |
NCT00431236 -
A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
|
Phase 3 | |
Completed |
NCT00405080 -
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
|
Phase 1 | |
Completed |
NCT00404274 -
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
|
Phase 1 | |
Completed |
NCT00440128 -
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
|
Phase 1 | |
Completed |
NCT00601172 -
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
|
Phase 3 | |
Completed |
NCT00511823 -
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
|
Phase 1 | |
Completed |
NCT00366834 -
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
|
Phase 3 | |
Completed |
NCT00437229 -
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
|
Phase 1 | |
Completed |
NCT00104403 -
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
|
Phase 2 | |
Completed |
NCT01449188 -
To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects
|
Phase 1 | |
Terminated |
NCT00334646 -
Cyclophosphamide Drug Interaction Study In Cancer Patients
|
Phase 1 |